Form 8-K - Current report:
SEC Accession No. 0001193125-23-113967
Filing Date
2023-04-25
Accepted
2023-04-25 06:51:52
Documents
12
Period of Report
2023-04-25
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d476548d8k.htm   iXBRL 8-K 28487
  Complete submission text file 0001193125-23-113967.txt   155198

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hlvx-20230425.xsd EX-101.SCH 2842
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hlvx-20230425_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hlvx-20230425_pre.xml EX-101.PRE 11702
6 EXTRACTED XBRL INSTANCE DOCUMENT d476548d8k_htm.xml XML 3453
Mailing Address 75 STATE ST. SUITE 100 BOSTON MA 02109
Business Address 75 STATE ST. SUITE 100 BOSTON MA 02109 (617) 213-5054
HilleVax, Inc. (Filer) CIK: 0001888012 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41365 | Film No.: 23841641
SIC: 2836 Biological Products, (No Diagnostic Substances)